NFE2L2 and COVID-19: Normalization with GAPDH, however, could not accurately capture the heterogeneity of the COVID-19 spectrum and that of CAM patients, and a significantly higher induction of NRF2 (1.3- to 268-fold in asymptomatic, mild, and moderate groups) was observed in COVID-19 patients (Fig. 4).